Cervical myelography with iohexol
- 1 March 1984
- journal article
- research article
- Published by Springer Nature in Neuroradiology
- Vol. 26 (2) , 123-129
- https://doi.org/10.1007/bf00339860
Abstract
An open study with iohexol (Omnipaque) in cervical myelography has been performed in 20 patients to evaluate the properties and neurotoxicity of this new water soluble contrast medium. The image quality was good (30%) or excellent (70%) in all cases. The frequency of headache was 25%. No EEG changes were severe and the total frequency was 20%. We conclude that this study supports other reports of iohexol having a low neurotoxicity and is well suited for intrathecal use.Keywords
This publication has 26 references indexed in Scilit:
- Experience with Iohexol in Lumbar MyelographyActa Radiologica. Diagnosis, 1983
- Functional Lumbar Myelography with IohexolActa Radiologica. Diagnosis, 1983
- The effect of lumbar puncture on the electroencephalogram.Journal of Neurology, Neurosurgery & Psychiatry, 1983
- A randomized blind trial of Iopamidol (Niopam) and Metrizamide (Amipaque) in lumber radiculographyNeuroradiology, 1983
- Iopamidol Vs metrizamide: A double blind study for cervical myelographyNeuroradiology, 1982
- Cervical myelography with iopamidoloNeuroradiology, 1981
- Complex partial status epilepticus following myelography with metrizamideAnnals of Neurology, 1980
- Mental disorders after myelography with metrizamide and other water-soluble contrast mediaNeuroradiology, 1980
- Subclinical organic psychosyndromes on intrathecal injection of metrizamide for lumbar myelographyNeuroradiology, 1979
- Thoracic and Cervical Myelography with MetrizamideRadiology, 1975